Solésence reports record full-year 2024 revenue of $52.3M, net income of $4.2M vs loss in 2023

SOLESENCE, INC.

Q4 revenue $12.6M (+57.5% YoY); gross profit $2.8M (22% margin) vs $0.5M (6%) in Q4 2023.
FY 2024 revenue $52.3M (+40% YoY); net income $4.2M vs net loss $4.4M in FY 2023.
Company rebranded as Solésence; plans to pursue NASDAQ uplisting and search for dedicated CFO in 2025.
Initiated expanded batch-making capacity at Bolingbrook facility to support over $200M annual revenue.
Launched over two dozen new SKUs in prestige and mass beauty; Au Lait Face Milk SPF 50+ won C&T Allē Award.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.